Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Aug 15;11(8):4614-4633.
eCollection 2019.

Modelling of atherosclerosis in genetically modified animals

Affiliations
Review

Modelling of atherosclerosis in genetically modified animals

Natalia V Mushenkova et al. Am J Transl Res. .

Abstract

Atherosclerosis is a lipid-driven, chronic inflammatory disease that leads to plaque formation at specific sites of the arterial tree. Being the common cause of many cardiovascular disorders, atherosclerosis makes a tremendous impact on morbidity and mortality rates of cardiovascular diseases (CVDs) in countries with higher income. Animal models of atherosclerosis are utilized as useful tools for studying the aetiology, pathogenesis and complications of atherosclerosis, thus, providing a valuable platform for the efficacy testing of different pharmacological therapies and validation of imaging techniques. To date, a large variety of models is available. Pathophysiological changes can be induced in animals by either an atherogenic diet or genetic manipulations. The discussion of advantages and disadvantages of some murine, rabbit and porcine genetic models currently available for the atherosclerosis research is the scope of the following review.

Keywords: Atherosclerosis; genetic animal models of human atherosclerosis; murine models of human atherosclerosis; porcine models of human atherosclerosis; rabbit models of human atherosclerosis.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

Figure 1
Figure 1
The utility of genetic rabbit models of human atherosclerosis. Note: WHHL - Watanabe Heritable Hyperlipidaemic; STH - St. Thomas’ Hospital; CETR - cholesteryl ester transfer protein; ApoB - apolipoprotein B; VLDL - very low-density lipoprotein.

References

    1. Orekhov AN, Ivanova EA. Introduction of the special issue “Atherosclerosis and Related Diseases”. Vessel Plus. 2017;1:163–5.
    1. Virmani R, Burke AP, Kolodgie FD, Farb A. Vulnerable plaque: the pathology of unstable coronary lesions. J Interv Cardiol. 2002;15:439. - PubMed
    1. Mohiaddin RH, Burman ED, Prasad SK, Varghese A, Tan RS, Collins SA, Hughes RL, Gatehouse PD, Jhooti P, Longmore DB, Yang GZ, Firmin DN, Pennell DJ. Glagov remodelling of the atherosclerotic aorta demonstrated by cardiovascular magnetic resonance: the CORDA asymptomatic subject plaque assessment research (CASPAR) project. J Cardiovasc Magn Reson. 2004;6:517–25. - PubMed
    1. McMahan CA, Gidding SS, Fayad ZA, Zieske AW, Malcom GT, Tracy RE, Strong JP, McGill HC. Risk scores predict atherosclerotic lesions in young people. Arch Intern Med. 2005;165:883–90. - PubMed
    1. Tzou WS, Douglas PS, Srinivasan SR, Bond MG, Tang R, Chen W, Berenson GS, Stein JH. Increased subclinical atherosclerosis in young adults with metabolic syndrome: the Bogalusa heart study. J Am Coll Cardiol. 2005;46:457–63. - PubMed

LinkOut - more resources